These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing]. Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404 [TBL] [Abstract][Full Text] [Related]
10. [Complication after implantable cardioverter defibrillator implantation: report of 1 case]. Lou ZY; Zhou MH; Li XQ Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642 [No Abstract] [Full Text] [Related]
11. Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Eur Heart J; 1992 Oct; 13(10):1304-10. PubMed ID: 1396800 [No Abstract] [Full Text] [Related]
12. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient. Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071 [TBL] [Abstract][Full Text] [Related]
13. Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator. Kolb C; Zrenner B; Schmitt C Int J Cardiol; 2006 Oct; 112(3):e74-5. PubMed ID: 16859778 [TBL] [Abstract][Full Text] [Related]
14. Short-long-short sequence caused by ventricular safety pacing inducing ventricular tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator. Hayashi M; Takatsuki S; Messali A; Milliez P; Extramiana F; Leenhardt A Europace; 2008 Oct; 10(10):1238-42. PubMed ID: 18617506 [TBL] [Abstract][Full Text] [Related]
15. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Sweeney MO Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472 [No Abstract] [Full Text] [Related]
17. How to avoid inappropriate therapy. Israel CW Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830 [TBL] [Abstract][Full Text] [Related]
18. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related]
19. Post automatic implantable cardioverter defibrillator implant therapies: drugs and ablative techniques. Colella A; Pieragnoli P; Ricciardi G; Giaccardi M; Padeletti L; Michelucci A Minerva Cardioangiol; 2007 Jun; 55(3):341-51. PubMed ID: 17534253 [TBL] [Abstract][Full Text] [Related]
20. Reappraisal of implant testing of implantable cardioverter defibrillators. Swerdlow CD J Am Coll Cardiol; 2004 Jul; 44(1):92-4. PubMed ID: 15234414 [No Abstract] [Full Text] [Related] [Next] [New Search]